Presentation AHA 2022 ISCHEMIA-EXTEND: ISCHEMIA Extended Follow-Up Interim Report Presenter: Judith S. Hochman November 07, 2022 REGISTER for free or LOG IN to view this content Coronary Presentation AHA 2022 Up Next Presentation AHA 2022 Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial Presenter: David E. Kandzari November 07, 2022 More slides + Presentation AHA 2022 Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial Presenter: Gregg W. Stone November 07, 2022 Presentation AHA 2022 Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial Presenter: Michelle L. O’Donoghue November 07, 2022 We Recommend
Presentation AHA 2022 Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial Presenter: David E. Kandzari November 07, 2022
Presentation AHA 2022 Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial Presenter: Gregg W. Stone November 07, 2022
Presentation AHA 2022 Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial Presenter: Michelle L. O’Donoghue November 07, 2022